EUVIMEDEUVIMED entdecken
Multizentrische Studie

An Oral Food Challenge Routinely Considered for Accurate Diagnosis of Peanut Allergy in Infants Prior to Oral Immunotherapy: Evaluation of the ADAPT Peanut Oral Immunotherapy Program

Timothy Brettig, Ellie McDonald, Danielle West, Rani Bhatia, Isabelle Bosi, Abigail Cheung, Helen Czech, Lara Ford, Constance Katelaris, Michael O'Sullivan, Jane Peake, Kahn Preece und 7 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2026-11 · 14 (11) · 2658-2668.e5

DOI: 10.1016/j.jaip.2026.08.044 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von Timothy Brettig und 18 weiteren Autor:innen. Beteiligte Einrichtung: National Allergy Centre of Excellence, Parkville, Victoria, Australia; Population Allergy Group, Murdoch Children's Research Institute, Parkville, Vi…. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Desensitization, Immunologic, Allergens. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Australian Federal Government, Murdoch Children's Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Oral immunotherapy (OIT) practices for food allergy vary globally. Whereas oral food challenges (OFCs) are not routinely performed before OIT, they can prevent unnecessary treatment. In 2024, the Allergy Development to an Accelerated Path to Tolerance (ADAPT) OIT program was established as the first nationally standardized model of care for treatment of peanut allergy. Threshold OFCs (TOFCs) were used to confirm peanut allergy and determine the OIT starting dose. OBJECTIVE: We evaluated the diagnostic accuracy and safety of this approach before starting OIT across the 10 ADAPT public hospital sites. METHODS: Infants aged less than 12 months with a history of Consortium for Food Allergy Research grade 1 to 2 reaction to peanut and sensitization (skin prick test result of 3 mm or greater or peanut/Ara h 2 specific IgE result 0.35 kUA/L or greater) were eligible. A TOFC involved seven escalating doses of 15-1,300 mg peanut protein). Data were collected by retrospective chart review. RESULTS: Between April 2024 and October 2025, we assessed 1,275 infants; 778 underwent TOFC (median age, 13 months). The TOFCs were positive in 65.2% (507 of 778), with median eliciting dose of 120 mg. Anaphylaxis occurred in 12.0% of positive OFCs (61 of 507; 7.8% overall). Median skin prick test and Ara h 2 specific IgE results were higher in positive versus negative TOFCs but did not predict the reaction threshold or severity. Among 394 infants commencing OIT, 97.5% (384 of 394) successfully initiated treatment at a dose below the TOFC-determined threshold. CONCLUSIONS: Within ADAPT, 34.8% of infants had negative TOFCs despite prior reactions and sensitization, enabling early delabeling. Although TOFCs carried an anaphylaxis risk, events were safely managed. Oral food challenge should be routinely considered in infant peanut allergy evaluation regardless of the proposed management strategy (immunotherapy or allergen avoidance).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peanut HypersensitivityDesensitization, ImmunologicAllergensHumansInfantMaleAdministration, OralFemaleSkin TestsImmunoglobulin EArachisRetrospective StudiesAntigens, Plant

Stichwörter der Autor:innen

DelabelingInfantOral food challengeOral immunotherapyPeanut allergy

Substanzen

Immunoglobulin EAllergensAntigens, Plant

Autor:innen und Institutionen

  • National Allergy Centre of Excellence, Parkville, Victoria, Australia; Population Allergy Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • National Allergy Centre of Excellence, Parkville, Victoria, Australia; Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • National Allergy Centre of Excellence, Parkville, Victoria, Australia.
  • Department of Paediatric Allergy and Immunology, John Hunter Children's Hospital, Newcastle, New South Wales, Australia; Department of Paediatrics, University of Newcastle, Newcastle, New South Wales, Australia.
  • Department of Allergy and Immunology, Children's Hospital at Westmead, Westmead, New South Wales, Australia; Department of Allergy and Clinical Immunology, Royal Prince Alfred Hospital, Campbelltown, New South Wales, Au…
  • Department of Paediatric Allergy and Clinical Immunology, SA Women's and Children's Network, Adelaide, South Australia, Australia.

Förderung

  • Australian Federal Government
  • Murdoch Children's Research Institute

Zitieren

APA

Brettig, T., McDonald, E., West, D., Bhatia, R., Bosi, I., Cheung, A., Czech, H., Ford, L., Katelaris, C., O'Sullivan, M., Peake, J., Preece, K., Quinn, P., Smart, J., Swamy, S., Wainstein, B., Wong, M., Perrett, K., & ADAPT OIT Working Group (2026). An Oral Food Challenge Routinely Considered for Accurate Diagnosis of Peanut Allergy in Infants Prior to Oral Immunotherapy: Evaluation of the ADAPT Peanut Oral Immunotherapy Program. The Journal of Allergy and Clinical Immunology: In Practice, 14(11), 2658-2668.e5. https://doi.org/10.1016/j.jaip.2026.08.044

Vancouver

Brettig T, McDonald E, West D, Bhatia R, Bosi I, Cheung A, et al. An Oral Food Challenge Routinely Considered for Accurate Diagnosis of Peanut Allergy in Infants Prior to Oral Immunotherapy: Evaluation of the ADAPT Peanut Oral Immunotherapy Program. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2658-2668.e5. doi:10.1016/j.jaip.2026.08.044

BibTeX
@article{Brettig2026,
  author = {Brettig, Timothy and McDonald, Ellie and West, Danielle and Bhatia, Rani and Bosi, Isabelle and Cheung, Abigail and Czech, Helen and Ford, Lara and Katelaris, Constance and O'Sullivan, Michael and Peake, Jane and Preece, Kahn and Quinn, Patrick and Smart, Joanne and Swamy, Shruti and Wainstein, Brynn and Wong, Melanie and Perrett, Kirsten and ADAPT OIT Working Group, ADAPT OIT Working Group},
  title = {An Oral Food Challenge Routinely Considered for Accurate Diagnosis of Peanut Allergy in Infants Prior to Oral Immunotherapy: Evaluation of the ADAPT Peanut Oral Immunotherapy Program},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {2658--2668.e5},
  doi = {10.1016/j.jaip.2026.08.044}
}
Kostenlos starten →